NEW YORK (GenomeWeb News) – Abbott said today that it will develop an automated molecular diagnostic PCR-based test that will be used to screen lung cancer tumors, under a collaboration with GlaxoSmithKline.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.
Scripps Research Institute investigators peer back at the RNA world.
Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.
In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.